Medical device manufacturer looks to revolutionize wound care with AI-driven nanosensors
COLUMBIA, Md., (February 11, 2026) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 Pre-Seed Builder Fund investment in NanoBioFAB. The Pre-Seed Builder Fund invests in and provides executive support to Maryland-based technology companies run by entrepreneurs who demonstrate economic disadvantages.
“The potential of our nanosensors to support a variety of healthcare challenges remains significant,” said Xiaonao Liu, Ph.D., CEO of NanoBioFAB. “Thanks to TEDCO’s resources and funding opportunities, NanoBioFAB continues growing and improving.”
NanoBioFAB, based in Frederick, Md., is a woman-owned medical device manufacturer specializing in AI-powered smart nanosensors for pathogen detection and wound management. The company’s technology seeks to address critical healthcare challenges through real-time monitoring and early detection of infections. Leveraging its patented nanosensor R&D and manufacturing technology NanoBioFAB develops sensors to detect trace amounts of gases released from pathogens, while also monitoring key parameters such as pressure, temperature and humidity. The company’s mission is to enhance health management and revolutionize wound care with its AI-driven nanosensors.
“The Social Impact Funds were created to provide opportunities to those traditionally overlooked,” said Jean-Luc Park, deputy chief investment officer & senior director of Social Impact Funds. “This investment in NanoBioFAB reflects our commitment to supporting the continued growth of Maryland’s ecosystem.”
NanoBioFAB has actively participated in several TEDCO programs and opportunities over the last few years. Those include Network Advisors, the Loaned Executive program, the Pre-Seed Builder Fund, the SBIR/STTR Proposal Lab, the Rural Business Innovation Initiative (RBII) grant and pre-seed funding, the Rural and Underserved Business Recovery from Impact of COVID-19 (RUBRIC) Program and more.
“Maryland is the third-ranking biopharma cluster in the United States, making the location perfect for researchers and innovators,” said TEDCO CEO, Troy LeMaile-Stovall. “Plus, with an abundance of resources and organizations like TEDCO, there is no question to why the State’s life sciences ecosystem continues to thrive.”
TEDCO provides funding, resources and connections that early-stage technology and life sciences companies need to thrive in Maryland. For entrepreneurs interested in applying for TEDCO funding opportunities, visit our page: https://www.tedcomd.com/funding.